Cytodyn Inc (CYDY)

[Saltz]

Z great to have you on board. Very good posts with insightful info.

For all that continue to question as to why It has taken too long to enroll 30 patients in the P3 Adjunct, do yourself a favor and READ Z's post. This is why Nader negotiated vehemently with the FDA to reduce patients from 300 to 150 to 30. Candidates that fit the profile are not easy to find. Regarding the P3 Mono Trial Nader has repeatedly stated "will be a much faster enrollment process". Nader and his team are competent at rolling out and implementing the shortest pathway to approval--however it is not as simple as one might think. Keep the posts coming Z.